Your browser doesn't support javascript.
loading
Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring.
Brady, Tyler; Zhang, Tianhui; Tuffy, Kevin M; Haskins, Nantaporn; Du, Qun; Lin, Jia; Kaplan, Gilad; Novick, Steven; Roe, Tiffany L; Ren, Kuishu; Rosenthal, Kim; McTamney, Patrick M; Abram, Michael E; Streicher, Katie; Kelly, Elizabeth J.
  • Brady T; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Zhang T; Data Sciences and Quantitative Biology, AstraZeneca, Gaithersburg, Maryland, USA.
  • Tuffy KM; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Haskins N; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Du Q; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Lin J; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Kaplan G; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Novick S; Data Sciences and Quantitative Biology, AstraZeneca, Gaithersburg, Maryland, USA.
  • Roe TL; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Ren K; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Rosenthal K; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • McTamney PM; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Abram ME; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Streicher K; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Kelly EJ; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
Microbiol Spectr ; 10(5): e0103422, 2022 10 26.
Article en En | MEDLINE | ID: mdl-35993765
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article